ClinicalTrials.Veeva

Menu

EffIcacy Between Arthrocentesis With High Versus Low Molecular Weight Hyaluronic Acid in Treatment of TMJ Disorders

B

Basel khaled mohamed

Status and phase

Enrolling
Phase 2
Phase 1

Conditions

Temporomandibular Joint Disorders
Arthrocentesis

Treatments

Device: Syringes
Drug: Hyaluronic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT06694532
Hyaluronic and TMJ Disorders

Details and patient eligibility

About

The study will be carried out in Patients in two Groups aged between 17 to 70 years , of both sexes, who had painful symptoms, with or without presence of joint noise, and had unilateral or bilateral internal derangement of the TMJ proven by clinical examination, with no improvement after conservative treatment.

Full description

The MEASUREMENT TOOL of the study will be carried out by 2 groups the first will be injected by high molecular weight hyaluronic acid and the second wil be injected by low molecular weight hyaluronic acid Then compare between Efectevness of injection of high-molecular weight versus Low moecular weight hyaluronic acid after two-needle arthrocentesis in improving the signs and symptoms of intra-articular TMJ disorder.

, 1- significantly improving the pain on scale 1-10 , and 2-significant improvements in mouth opening range in mm by the distance between the edges of the frontal incisors with a ruler or caliper and joint noise.

3-The presence of absence of clicking and cracking in jaw .

Enrollment

30 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pain or tenderness of the jaw
  • Pain in one or both of the temporomandibular joints
  • Aching pain in and around your ear
  • Difficulty chewing or pain while chewing
  • Aching facial pain
  • Locking of the joint,

Exclusion criteria

  • Muscular TMJ disorders
  • Bleeding tendency

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

high molucular weight hyalurinic acid .
Experimental group
Description:
patients injected e high molucular weight hyalurinic acid .
Treatment:
Drug: Hyaluronic acid
Device: Syringes
low molcular weight hyaurinic acid
Experimental group
Description:
patients injected with low molucular weight hyalurinic acid .
Treatment:
Drug: Hyaluronic acid
Device: Syringes

Trial contacts and locations

1

Loading...

Central trial contact

Basel K Mohamed; Basel K Mohamed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems